Ethyl 2-azabicyclo[3.1.0]hexane-1-carboxylate hydrochloride, 98%, 250mg

Glycol aldehyde, dimer, 1 g, glass packaging

1-(2-chloro-5-nitrobenzoyl)piperazine, 95.0%, 1g

GC capillary column ROTI®Cap-5, 30 m, 0.32 mm, 5.00 µm, 1 Piece(s)

4,4'-Biphenyldicarbonyl chloride, 97.0%, 5g

2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-chlorobenzoic acid, 95.0%, 1g

tert-Butyl 4-(ethoxycarbonylamino)piperidine-1-carboxylate, 95.0%, 1g

1-(5-Chloro-2-hydroxy-3-methylphenyl)ethan-1-one, 97%, 1g

ETHYL 4-METHYL-5-OXO-2,5-DIHYDROISOXAZOLE-3-CARBOXYLATE, 95.0%, 500mg

4'-Bromo-2,2,2-trifluoroacetophenone, 97.0%, 500g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)picolinaldehyde, 98%, 250mg

4-Methyl-2-[4-(trifluoromethyl)phenyl]thiazole-5-carboxylic acid, 95.0%, 1g

1,3-Di(adamantan-1-yl)-1H-imidazol-3-ium chloride, 95.0%, 1g